Published Guidance, NICE advice and quality standards

Skip to filtersSkip to results

Skip to results

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme 1 selected

Guidance programme

Showing 541 to 550 of 761

TitleReference numberPublishedLast updated
Talimogene laherparepvec for treating unresectable metastatic melanomaTA410
Bosutinib for previously treated chronic myeloid leukaemiaTA401
Pemetrexed maintenance treatment for non-squamous non-small-cell lung cancer after pemetrexed and cisplatinTA402
Ramucirumab for previously treated locally advanced or metastatic non-small-cell lung cancerTA403
Degarelix for treating advanced hormone-dependent prostate cancerTA404
Trifluridine–tipiracil for previously treated metastatic colorectal cancerTA405
Cabazitaxel for hormone-relapsed metastatic prostate cancer treated with docetaxelTA391
Abiraterone for castration-resistant metastatic prostate cancer previously treated with a docetaxel-containing regimenTA259
Lumacaftor–ivacaftor for treating cystic fibrosis homozygous for the F508del mutationTA398
Azacitidine for treating acute myeloid leukaemia with more than 30% bone marrow blastsTA399

Results per page

  1. 10
  2. 25
  3. 50
  4. All